Dr Becky Inkster University positionHonorary Research Fellow DepartmentsHome pagehttp://www.beckyinkster.com (personal home page) Research ThemesInterestsI am a Neuroscientist passionate about digital interventions in mental health, social media data analysis, genomics, molecular biology, and neuroimaging. I am passionate about working with hard-to-reach, disadvantaged groups and youth culture. I am a Co-Founder of HIP HOP PSYCH, which uses hip-hop as a vehicle for cultivating awareness about mental health, for public engagement, teaching innovation, refining psychotherapies and psychoeducation. I have further interests in GSK3beta, EPO clinical trials for mood disorders and how the human kinome maps to disease and health. My affiliations include: Honorary Research Fellow, Department of Psychiatry, University of Cambridge, UK Visiting Scholar, School of Social Work, Columbia University, NYC, USA Co-Founder of Hip Hop Psych Academic Freelance (Sole Trader) Touchkin Advisor Conference Lead: Digital Interventions in Mental Health  I am interested in learning how social networking site data, such as social network structure, can help us understand mental health conditions Click image to view full-size Research Focus
EquipmentBehavioural analysis Immunohistochemistry Magnetic resonance imaging (MRI) Neuropsychological testing Randomised control trials Turntables CollaboratorsNo collaborators listed Associated News Items
Key publicationsInkster B, Kosinski M, Stillwell D (in submission), “Neuroscience in the digital age” Nature Neuroscience Inkster B, Stillwell D, Kosinski M, Jones P (in submission), “A decade into Facebook: where is psychiatry in the digital age?” The Lancet Psychiatry Miskowiak KW, Vinberg M, Macoveanu J, Ehrenreich H, Køster N, Inkster B, Paulson OB, Kessing LV, Skimminge A, Siebner HR (2015), “Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders” Biol Psychiatry 78(4): 270-7 Sule A, Inkster B (2015), “Kendrick Lamar, street poet of mental health” The Lancet Psychiatry 2(6): 496-7 Publicationsin submissionInkster B, Simmons A, Cole J, Schoof E, Linding R, Nichols T, Whitcher B, Muglia P, Rao A, Auer DP, Holsboer F, Saemann P, McGuffin P, Fu C, Zai G, Miskowiak KW, Matthews PM, Nicodemus K (in submission), “Replicated epistasis relates to GSK3beta, hippocampal volume and major depressive disorder” Molecular Psychiatry Inkster B, Zai G, Lewis G, Miskowiak KW (in submission), “GSK3β: a plausible mechanism of hippocampal change induced by erythropoietin treatment in mood disorders” Molecular Psychiatry 2015Inkster B Sule A (2015), “Drug term trends in American hip-hop lyrics ” Journal of Public Mental Health 14(3): 169-173 Toseeb U, Inkster B (2015), “Online social networking sites and mental health research” Front Psychiatry 6(36): 1-4 2014Sule A, Inkster B (2014), “A hip-hop state of mind” The Lancet Psychiatry 1(7):494-5 2013Inkster B, Strijbis EM, Vounou M, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ (2013), “Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.” Neurobiol Aging 34(1):238-47 Details Strijbis EM, Inkster B, Vounou M, Naegelin Y, Kappos L, Radue EW, Matthews PM, Uitdehaag BM, Barkhof F, Polman CH, Montana G, Geurts JJ (2013), “Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.” Mult Scler 19(3):281-8 Details Weiskopf N, Suckling J, Williams G, Correia MM, Inkster B, Tait R, Ooi C, Bullmore ET, Lutti A (2013), “Quantitative multi-parameter mapping of R1, PD(*), MT, and R2(*) at 3T: a multi-center validation.” Front Neurosci 7:95 Details 2012Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ (2012), “GABA system dysfunction in autism and related disorders: from synapse to symptoms.” Neurosci Biobehav Rev 36(9):2044-55 Details Inkster B, Rao AW, Ridler K, Filippini N, Whitcher B, Nichols TE, Wetten S, Gibson RA, Borrie M, Kertesz A, Guzman DA, Loy-English I, Williams J, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM (2012), “Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease.” Neurobiol Aging 33(3):457-65 Details 2011Dixson L, Ridler K, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM, Inkster B (2011), “Thyroid hormone transporter genes and grey matter changes in patients with major depressive disorder and healthy controls.” Psychoneuroendocrinology 36(6):929-34 Details Inkster B, Rao AW, Ridler K, Nichols TE, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM (2011), “Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms.” J Neuroimaging 21(4):375-82 Details 2010Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2010), “Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression.” Neuroimage 53(3):908-17 Details Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ (2010), “Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.” Psychopharmacology (Berl) 210(3):419-28 Details 2009Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2009), “Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.” Arch Gen Psychiatry 66(7):721-8 Details Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ (2009), “Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.” Psychopharmacology (Berl) 207(1):133-42 Details 2008Mannie ZN, Norbury R, Murphy SE, Inkster B, Harmer CJ, Cowen PJ (2008), “Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression.” Br J Psychiatry 192(5):356-61 Details Miskowiak K, Inkster B, O'Sullivan U, Selvaraj S, Goodwin GM, Harmer CJ (2008), “Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.” Exp Brain Res 184(3):313-21 Details Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ (2008), “Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.” Neuropsychopharmacology 33(3):611-8 Details 2007Miskowiak K, Inkster B, Selvaraj S, Goodwin G, Harmer C (2007), “Erythropoietin has no effect on hippocampal response during memory retrieval 3 days post-administration.” Psychopharmacology (Berl) 195(3):451-3 Details 2004Inkster B, Muglia P, Jain U, Kennedy JL (2004), “Linkage disequilibrium analysis of the dopamine beta-hydroxylase gene in persistent attention deficit hyperactivity disorder.” Psychiatr Genet 14(2):117-20 Details 2002Muglia P, Jain U, Inkster B, Kennedy JL (2002), “A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD.” Neuropsychopharmacology 27(4):655-62 Details |